Market Size of Far Infrared Therapy Device Industry
Study Period | 2019 - 2029 |
Market Size (2024) | USD 1.48 Billion |
Market Size (2029) | USD 2.03 Billion |
CAGR (2024 - 2029) | 6.55 % |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Market Concentration | Medium |
Major Players*Disclaimer: Major Players sorted in no particular order |
Far Infrared Therapy Device Market Analysis
The Far Infrared Therapy Device Market size is estimated at USD 1.48 billion in 2024, and is expected to reach USD 2.03 billion by 2029, at a CAGR of 6.55% during the forecast period (2024-2029).
Factors such as the rising burden of chronic diseases, increasing demand for non-invasive treatments, growing awareness about far infrared therapy devices, and technological advancements are expected to boost the growth of the far infrared therapy devices market over the forecast period.
Rising rates of cardiovascular diseases and diabetes are driving the demand for non-invasive pain relief solutions, such as far infrared therapy devices, as they support heart health and improve vascular functions, fueling market growth. For instance, data from the International Federation of Diabetes, updated in 2024, indicated that globally, around 643 million people are projected to suffer from diabetes by 2030, with this figure set to rise to 784 million by 2045. Far infrared therapy boosts blood flow, potentially aiding individuals with diabetes by improving circulation and reducing related complications. This trend is poised to propel market growth during the forecast period.
Moreover, several research studies have evaluated the impact of far-infrared therapy devices on the maturation and longevity of arteriovenous fistulas in hemodialysis patients. For instance, an article published in Frontiers in Surgery in September 2023 highlighted far infrared therapy as a promising treatment for arteriovenous fistulas in hemodialysis patients. The study found that it can effectively enhance arteriovenous fistula maturity, increase venous diameter, and boost both pump-controlled blood flow and brachial artery blood flow during dialysis, ultimately extending the lifespan of hemodialysis patients suffering from arteriovenous. This demonstrates that far infrared therapy is set to emerge as a significant treatment approach for arteriovenous fistulas, further driving market growth.
Similarly, researchers evaluated the efficacy of far-infrared (FIR) rays produced by graphene-based hyperthermia devices in addressing metabolic disorders. For instance, an article published in Scientific Reports in July 2024 highlighted the findings that graphene-FIR not only elevates core and epidermal temperatures but also boosts blood circulation in the femoral muscle and abdominal areas. Furthermore, a combined microbiomic and metabolomic analysis indicated that graphene-FIR influences the gut-muscle axis metabolism. These groundbreaking insights into graphene-FIR's therapeutic potential underscore its promise as a mimetic agent for managing metabolic disorders, suggesting a significant boost to market growth in the coming years.
Furthermore, the introduction of far-infrared therapy devices is set to enhance their acceptance among target demographics, further propelling market growth. For instance, in November 2023, DeRUCCI Group unveiled the DeRUCCI T11 Pro Smart Mattress. This AIoT-driven intelligent sleep solution is the first of its kind, adjusting in real-time to optimize sleep based on individual health metrics and even alerting users to potential health concerns. The mattress also offers far-infrared graphene thermal warmth for warm feet, ensuring a more comfortable sleep during the cold winter months.
Similarly, in March 2023, the Joseph N France General Hospital received and commissioned two Far-Infrared Therapy machines donated by the Taipei Veterans General Hospital and the WS Far IR Medical Technology Co. Ltd in Taiwan. With these devices, the hospital aims to effectively treat various conditions, including arthritis, back pain, and muscle spasms.
Therefore, owing to factors such as the rising burden of diabetes, increasing application of far infrared therapy in hemodialysis patients with arteriovenous fistula maturation as well as studies evaluating graphene FIR for metabolic diseases, and new product launches, the market studied is expected to grow over the forecast period. However, the high cost of devices and the presence of alternate therapies are likely to impede market growth over the forecast period.